Cencora balance sheet
At the end of fiscal 2025, Cencora had total assets of $76.59bn and shareholders' equity of $1.51bn. It held $4.36bn in cash against $7.66bn of debt.
Balance sheet
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.0 | 1.7 | 1.8 | 1.1 | 1.2 | 1.8 | 2.2 | 2.7 | 2.4 | 2.5 | 3.4 | 4.6 | 2.5 | 3.4 | 2.6 | 3.1 | 4.4 | 2.8 |
| Receivables | 3.9 | 3.8 | 3.8 | 3.8 | 6.1 | 6.3 | 8.2 | 9.2 | 10.3 | 11.3 | 12.4 | 13.8 | 18.2 | 18.5 | 20.9 | 23.9 | 25.2 | 25.4 |
| Inventory | 5.0 | 5.2 | 5.4 | 5.5 | 7.0 | 8.6 | 9.8 | 10.7 | 11.5 | 11.9 | 11.1 | 12.6 | 15.4 | 15.6 | 17.5 | 19.0 | 20.5 | 21.0 |
| Total current assets | 10.0 | 10.7 | 11.4 | 11.1 | 14.4 | 16.8 | 20.3 | 22.9 | 24.3 | 25.9 | 28.1 | 33.1 | 38.8 | 39.6 | 42.8 | 47.7 | 52.2 | 55.3 |
| Goodwill | 2.5 | 2.5 | 2.5 | 2.9 | 2.9 | 2.9 | 4.1 | 6.0 | 6.0 | 6.7 | 6.7 | 6.7 | 9.0 | 8.5 | 9.6 | 9.3 | 13.7 | 16.5 |
| Total assets | 13.6 | 14.4 | 15.0 | 15.4 | 18.9 | 21.5 | 28.0 | 33.6 | 35.3 | 37.7 | 39.2 | 44.3 | 57.3 | 56.6 | 62.6 | 67.1 | 76.6 | 83.8 |
| Accounts payable | 8.5 | 8.8 | 9.2 | 9.5 | 13.3 | 15.6 | 20.9 | 23.9 | 25.4 | 26.8 | 28.4 | 31.7 | 38.0 | 40.2 | 45.8 | 50.9 | 54.7 | 54.7 |
| Total current liabilities | 9.5 | 9.9 | 10.9 | 11.3 | 14.9 | 17.3 | 21.6 | 25.3 | 26.8 | 27.9 | 29.6 | 33.9 | 41.4 | 43.5 | 48.8 | 54.3 | 57.8 | 59.2 |
| Short-term debt | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | — | 0.0 | 0.6 | 0.0 | 0.2 | 0.1 | 0.5 | 0.3 | 1.1 | 0.6 | 0.6 | 0.1 | 0.3 |
| Long-term debt | 1.2 | 1.3 | 1.0 | 1.4 | 1.4 | 2.0 | 3.5 | 3.6 | 3.4 | 4.2 | 4.0 | 3.6 | 6.4 | 4.6 | 4.1 | 3.8 | 7.5 | 11.4 |
| Total debt | 1.2 | 1.3 | 1.4 | 1.4 | 1.4 | 2.0 | 3.5 | 4.2 | 3.5 | 4.5 | 4.2 | 4.1 | 6.7 | 5.7 | 4.8 | 4.4 | 7.7 | 11.7 |
| Shareholders' equity | 2.7 | 3.0 | 2.9 | 2.5 | 2.3 | 1.9 | 0.6 | 2.1 | 2.1 | 2.9 | 2.9 | −1.0 | 0.2 | −0.2 | 0.5 | 0.6 | 1.5 | 3.1 |
| Shares outstanding | 288m | 278m | 261m | 235m | 230m | 222m | 207m | 220m | 218m | 213m | 207m | 204m | 208m | 206m | 201m | 195m | 194m | 191m |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 23.9 | 24.5 | 23.7 | 24.6 | 25.2 | 26.0 | 24.9 | 25.4 |
| Inventory | 19.0 | 20.5 | 19.0 | 20.1 | 20.5 | 24.1 | 20.0 | 21.0 |
| Total current assets | 47.7 | 50.0 | 46.5 | 48.8 | 52.2 | 54.2 | 53.1 | 55.3 |
| Goodwill | 9.3 | 9.2 | 14.1 | 14.3 | 13.7 | 13.7 | 16.5 | 16.5 |
| Total assets | 67.1 | 69.1 | 71.2 | 74.0 | 76.6 | 78.4 | 81.7 | 83.8 |
| Accounts payable | 50.9 | 49.9 | 50.1 | 51.0 | 54.7 | 56.1 | 51.9 | 54.7 |
| Total current liabilities | 54.3 | 54.5 | 53.3 | 54.0 | 57.8 | 59.1 | 56.1 | 59.2 |
| Short-term debt | 0.6 | 2.2 | 0.8 | 0.2 | 0.1 | 0.3 | 0.2 | 0.3 |
| Long-term debt | 3.8 | 5.9 | 7.1 | 8.0 | 7.5 | 7.6 | 12.2 | 11.4 |
| Total debt | 4.4 | 8.1 | 7.9 | 8.2 | 7.7 | 7.9 | 12.4 | 11.7 |
| Shareholders' equity | 0.6 | 0.2 | 1.0 | 2.0 | 1.5 | 1.9 | 3.4 | 3.1 |
| Shares outstanding | 195m | 194m | 194m | 194m | 194m | 195m | 195m | 191m |
Compare with peers
- McKesson balance sheet
- Henry Schein balance sheet
- 111, Inc. balance sheet
- Cosmos Health Inc. balance sheet
- Cellyan Biotechnology Co., Ltd balance sheet
Head to head: COR vs MCKCOR vs HSICCOR vs YI
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies